Failure to Prevent Unnecessary Drug Use and Monitor Medication Interactions
Summary
The facility failed to ensure that a resident’s drug regimen was free from unnecessary drugs, as evidenced by the administration of multiple psychotropic and opioid medications without adequate monitoring or documented justification. The resident, who had a history of vertebral fracture, scoliosis, osteoarthritis, and depression, was prescribed risperidone (an antipsychotic) on an as-needed basis for behaviors, as well as multiple opioid medications for pain management. There was no documented stop date or duration for the risperidone, and the order included instructions to follow up with the primary health care provider, but there was no evidence of such follow-up or of regular evaluation of the continued need for the medication. The resident’s medical records showed frequent administration of both antipsychotic and opioid medications, sometimes concurrently, despite a black box warning regarding the risks of combining these drug classes. Documentation was lacking regarding the specific behaviors that prompted the use of the antipsychotic, and there was no evidence of non-pharmacological interventions for pain. Progress notes indicated a decline in the resident’s cognition and physical abilities, with concerns raised by both staff and the resident’s representative. Despite these concerns and requests for medication review, there was no documented evidence that the need for continued use of the antipsychotic or the potential drug interactions were addressed by providers. Interviews with staff and the resident’s representative confirmed that the resident experienced periods of significant cognitive and physical decline, which improved after changes to the medication regimen. The representative was not informed about the initiation of the antipsychotic and expressed concern about the resident’s decline. Staff acknowledged missed opportunities to evaluate for over-medication and potential drug interactions. The facility’s failure to monitor and evaluate the resident’s medication regimen, document the rationale for continued use, and communicate with the resident’s representative contributed to the deficiency.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.